Artificial intelligence outperforms standard blood-based scores in identifying liver fibrosis patients in primary care.

Bibliographic Details
Title: Artificial intelligence outperforms standard blood-based scores in identifying liver fibrosis patients in primary care.
Authors: Blanes-Vidal, Victoria1,2 (AUTHOR) vbv@mmmi.sdu.dk, Lindvig, Katrine P.3,4 (AUTHOR), Thiele, Maja3,4 (AUTHOR), Nadimi, Esmaeil S.1,2 (AUTHOR), Krag, Aleksander3,4 (AUTHOR)
Source: Scientific Reports. 2/21/2022, Vol. 12 Issue 1, p1-11. 11p.
Subject Terms: *HEPATIC fibrosis, *ARTIFICIAL intelligence, *PRIMARY care, *PATIENT care, *ASYMPTOMATIC patients, *CHRONIC hepatitis B
Abstract: For years, hepatologists have been seeking non-invasive methods able to detect significant liver fibrosis. However, no previous algorithm using routine blood markers has proven to be clinically appropriate in primary care. We present a novel approach based on artificial intelligence, able to predict significant liver fibrosis in low-prevalence populations using routinely available patient data. We built six ensemble learning models (LiverAID) with different complexities using a prospective screening cohort of 3352 asymptomatic subjects. 463 patients were at a significant risk that justified performing a liver biopsy. Using an unseen hold-out dataset, we conducted a head-to-head comparison with conventional methods: standard blood-based indices (FIB-4, Forns and APRI) and transient elastography (TE). LiverAID models appropriately identified patients with significant liver stiffness (> 8 kPa) (AUC of 0.86, 0.89, 0.91, 0.92, 0.92 and 0.94, and NPV ≥ 0.98), and had a significantly superior discriminative ability (p < 0.01) than conventional blood-based indices (AUC = 0.60–0.76). Compared to TE, LiverAID models showed a good ability to rule out significant biopsy-assessed fibrosis stages. Given the ready availability of the required data and the relatively high performance, our artificial intelligence-based models are valuable screening tools that could be used clinically for early identification of patients with asymptomatic chronic liver diseases in primary care. [ABSTRACT FROM AUTHOR]
Copyright of Scientific Reports is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Academic Search Complete
Full text is not displayed to guests.
More Details
ISSN:20452322
DOI:10.1038/s41598-022-06998-8
Published in:Scientific Reports
Language:English